Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Soon: New Calculations...

    Soon: New Calculations to come at Ceiling Prices for Essential Medicines

    Written by Ruby Khatun Khatun Published On 2018-07-01T10:55:43+05:30  |  Updated On 1 July 2018 10:55 AM IST
    Soon: New Calculations to come at Ceiling Prices for Essential Medicines

    New Delhi: Essential medicines in the country are likely to become further reasonable and cheaper as the government is now considering a proposal to cap the prices of the drugs at the first point of sale rather than retail price. The move is expected to curb down the margins offered to the hospitals, distributors, and doctors in order to push particular brands


    Niti Aayog has submitted a proposal to the Prime Minister’s Office suggesting the change in the current mechanism of price fixing to check the inflated prices of the essential medicines.


    Market and institutional data such as costs at central, state and private hospitals will be used to arrive at ceiling prices.


    Presently, the prices of the essential drugs are capped on the average price to the retailer of all brands of any particular medicine with at least 1 percent market share including all trade margins, except for the retailer margin, which is fixed at 16 percent and added to the ceiling price to arrive at an MRP.


    Under the current pricing mechanism, 8 percent margin is fixed for wholesaler, it is usually not closely monitored as it is inbuilt in the ‘price to retailer’ –used for calculating ceiling price which, Niti Aayog says, is an opaque procedure that lends to profiteering.


    TOI confirms that Niti Aayog has proposed to use ‘average price at the first point of sale’, or price to the stockist, wholesaler, distributor or hospital for calculation of ceiling price and fixing a total trade margin of 24% which can be added to the ceiling price to arrive at MRP.


    The drug makers currently have the flexibility to change prices by altering trade margins given to distributors and retailers which includes heavy expenses on marketing and promoting drug brands among hospitals and doctors.

    Distributorsdoctorsdomestic pharmaceutical marketsessential medicinesfirst point of salegovernmenthospitalsNiti AayogPrime Minister Officetrade margins
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok